Fig. 2: Relapse-free survival of patients with Ph-negative ALL based on NGS MRD response after cycle 1.
From: Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL
A Standard-risk ALL, and B high-risk ALL.
Fig. 2: Relapse-free survival of patients with Ph-negative ALL based on NGS MRD response after cycle 1. | Blood Cancer Journal
